Bromocriptine: 6 sep 2013: "european union (eu) regulators announced today that they will study whether the cardiovascular, neurological, ; psychiatric risks of using bromocriptine to inhibit lactation in women after childbirth outweigh the drug's benefits. The us food and drug administration (fda) withdrew the drug's indication for lactation suppression in 1994 because of the risk for heart attack ; stroke.".
Answered 4/15/2019
4.8k views
A doctor has provided 1 answer
A doctor has provided 1 answer
2 doctors weighed in across 2 answers
A doctor has provided 1 answer
8 doctors weighed in across 5 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question